Advanced Filters
noise

a, a N Clinical Trials

A listing of a, a N clinical trials actively recruiting patients volunteers.

Found 11,315 clinical trials
A Angela Cavalagli, MD

Pediatric Upper-Limb Rehabilitation With PhiCube, a Modular Bilateral End-Effector Device

The present investigation is configured as a multicenter clinical study in a within-group pilot phase. This study aims to investigate primarily the feasibility of use and effectiveness of a treatment for upper limb function in children aged 4 to 18 years with congenital and acquired neuromotor disorders through a new …

4 - 18 years of age All Phase N/A
B Boehringer Ingelheim

A Study in Healthy People to Test How Vicadrostat Affects the Heart

The main objective of this trial is to investigate the effect of vicadrostat on the heart compared with placebo in healthy male and female volunteers.

18 - 50 years of age All Phase 1
T Tatiana ONEA, MD

Experience of UHR and PEP Individuals During Mindfulness: a Qualitative Phenomenological Study

The goal of this qualitative study is to explore and describe the lived experiences of individuals at ultra-high risk (UHR) or first episode of psychosis (FEP) who have participated in a group-based mindfulness-based intervention. Secondary objectives include identifying potential adverse effects of a group-based mindfulness-based intervention among UHR or FEP.

15 - 30 years of age All Phase N/A
H Herui Yao

A Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies

This is a Phase I, multicenter, open-label, single-arm and first-in-human clinical study of BRY812 for injection. The study objectives are to evaluate the safety, tolerability, pharmacokinetic profile, anti-tumor activity and immunogenicity of BRY812 for injection in patients with advanced malignancies. Patients will receive treatment every 3 weeks until intolerable toxicity, …

18 years of age All Phase 1
P Philippe Nadeau, Ph.D.

Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager

Bispecific antibody therapies targeting BCMA (B-cell maturation antigen) represent a novel therapeutic approach for patients with multiple myeloma. They are currently used in cases of refractory multiple myeloma but are also being investigated in earlier lines of treatment. However, these new therapies can lead to deeper immunosuppression and exacerbate an …

18 years of age All Phase 4
Q Qiubai Li, Professor

Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis

The primary objective of the study was to evaluate the safety and tolerability of A-319 in patients with active rheumatoid arthritis.

18 - 70 years of age All Phase 0
W Weili Zhao, M.D. and Ph.D

A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

This study aims to observe and explore the efficacy and safety of obinutuzumab-based therapy for previously untreated follicular lymphoma

18 years of age All Phase N/A
K Kristin Rooney

GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

35 - 40 years of age Female Phase N/A
R Richard Paulson, MD

Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation

The goal of this clinical trial is to evaluate a long Clomid protocol as compared to a 5-day Clomid protocol for ovarian stimulation in patients with diminished ovarian reserve undergoing ovarian stimulation for in-vitro fertilization. The aim of the long Clomid protocol is to intensify stimulation of the ovaries and …

18 - 45 years of age Female Phase 4

A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects

The safety, tolerability, and pharmacokinetic/pharmacodynamic (PK/PD) characteristics study of HEC169584 capsules in healthy subjects .

18 - 45 years of age All Phase 1

Simplify language using AI